Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Northwest Biotherapeutics ( (NWBO) ) just unveiled an update.
On October 27, 2025, Northwest Biotherapeutics, Inc. entered into a Commercial Loan Agreement with Streeterville Capital, LLC for $5,505,000. The loan has a 22-month maturity with no repayments for the first 8 months, followed by 14 monthly installments starting June 26, 2026. The funds will support ongoing business operations.
More about Northwest Biotherapeutics
Average Trading Volume: 3,437,796
Technical Sentiment Signal: Strong Sell
Current Market Cap: $358M
See more insights into NWBO stock on TipRanks’ Stock Analysis page.